Skip to main content
. 2019 Sep 23;14(9):e0222515. doi: 10.1371/journal.pone.0222515

Fig 1. Subconjunctival injections of BM-MSCs prolonged corneal allograft survival with alleviated corneal opacity, edema and neovascularization.

Fig 1

(A) Representative pictures of the corneal allografts from PBS- and BM-MSC-treated group at day 3, 7, and 10 post-operation. (B) Kaplan-Meier survival curve of corneal allografts (n = 8 / group). (C) Comparison of the mean survival time (MST) of the corneal allografts between the two groups (n = 8 / group). (D, E, F) The scores of opacity, edema, and neovascularization of the corneal allografts following penetrating keratoplasty.